https://doi.org/10.4081/hls.2024.12563
New aspects of immunological risk factors in the treatment of recurrent pregnancy loss
Submitted: 12 April 2024
Accepted: 14 June 2024
Published: 8 August 2024
Accepted: 14 June 2024
Abstract Views: 776
PDF: 257
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Recurrent Pregnancy Loss (RPL) is diagnosed in 3% of all patients of reproductive age and is of high interest to reproductive medicine specialists. Immunological predispositions are among the crucial risk factors for RPL development in female patients suffering from RPL. Therefore, the purpose of this work is to investigate the role and effectiveness of individualised immunological treatment approaches by analysing several clinical cases with diagnosed pregnancy loss and the results of tailored immunological therapies. Based on 25 years of clinical experience and scientific research the paper analysed the relationship between Human Leukocyte Antigens (HLA) tissue compatibility and ABO blood group system incompatibility in immunological pregnancy failure. The connection of these factors was shown in 2 clinical cases suffering from RPL who agreed to participate in research. Research was performed at Nakhchivan Birth Center and Nakhchivan State University. The results of the study provided evidence based on these cases of RPL that ended with successful childbirth after the suggested genetic assessment and immunological treatment. Individual treatment of immunological pregnancy failure with HLA and ABO blood group incompatibilities showed more effective outcomes if compared to previous schemes of treatment. HLA compatibility in loci 3 combined with affinity on the ABO system strongly demanded immunological therapy prescription for successful implantation of the blastocyst. The outcomes obtained from the study can be implemented in obstetrics and gynecology for the improvement of clinical cases suffering from RPL.
Svyatova GS, Mirzakhmetova DD, Berezina GM, Murtazaliyeva AV. Genetic factors of idiopathic recurrent miscarriage in Kazakh population. J Reprod Infertil 2022;23:39-45.
DOI: https://doi.org/10.18502/jri.v23i1.8451
Boichuk OH, Dorofeieva US, Kolomiichenko TV. Hormonal and genetic causes of poor response to controlled ovarian stimulation in women of late reproductive age. Reprod Endocrinol 2022;66:62-7.
DOI: https://doi.org/10.18370/2309-4117.2022.66.62-67
Chester MR, Tirlapur A, Jayaprakasan K. Current management of recurrent pregnancy loss. Obstet Gynecol 2022;24:260-71.
DOI: https://doi.org/10.1111/tog.12832
Moqadami A, Rezaei A, Ahmadi A, et al. Investigating the association of MTHFR C677T gene polymorphism with recurrent spontaneous abortion among Azerbaijani women from northwest Iran. Genet Test Mol Biomarkers 2023;27:339-44.
DOI: https://doi.org/10.1089/gtmb.2023.0330
Yousefian M, Angaji SA, Siasi E, et al. Association of polymorphisms of F2 (rs3136520) and PAI-1 (rs6090) Genes with recurrent pregnancy loss in Iranian Azeri women. Avicenna J Clin Med 2021;28:118-25.
DOI: https://doi.org/10.52547/ajcm.28.2.118
Abbaszadeh E, Rahmani SA, Danaei Mehrabad S. Prevalence of mutations in V Leiden and prothrombin genes in women with recurrent pregnancy loss: a retrospective study on Iranian Azeri women. J Basic Res Med Sci 2020;7:22-7.
Vomstein K, Feil K, Strobel L, et al. Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art. J Clin Med 2021;10:869.
DOI: https://doi.org/10.3390/jcm10040869
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012;98:1103-11.
DOI: https://doi.org/10.1016/j.fertnstert.2012.06.048
Regan L, Rai R, Saravelos S, et al. Recurrent miscarriage: green-top guideline No. 17. BJOG 2023;130:e9-e39.
DOI: https://doi.org/10.1111/1471-0528.17515
Zhao X, Wang S, Du T, et al. Demystifying the landscape of endometrial immune microenvironment in luteal-phase from cuprotosis: implications for the mechanism and treatment of RPL. Gene 2024;903:148191.
DOI: https://doi.org/10.1016/j.gene.2024.148191
Tomkiewicz J, Darmochwał-Kolarz D. The diagnostics and treatment of recurrent pregnancy loss. J Clin Med 2023;12:4768.
DOI: https://doi.org/10.3390/jcm12144768
Shields R, Hawkes A, Quenby S. Clinical approach to recurrent pregnancy loss. Obstet Gynaecol Reprod Med 2020;30:331-6.
DOI: https://doi.org/10.1016/j.ogrm.2020.09.005
Carbonnel M, Pirtea P, de Ziegler D, Ayoubi JM. Uterine factors in recurrent pregnancy losses. Fertil Steril 2021;115:538-45.
DOI: https://doi.org/10.1016/j.fertnstert.2020.12.003
Habets DH, Al-Nasiry S, Nagelkerke SQ, et al. Analysis of FCGR3A-p.176Val variants in women with recurrent pregnancy loss and the association with CD16a expression and anti-HLA antibody status. Sci Rep 2023;13:5232.
DOI: https://doi.org/10.1038/s41598-023-32156-9
Ayazbekov A, Nurkhasimova R, Ibrayeva D, et al. Evaluation of women’s health with intrauterine fetal death in the city of Turkestan for the years of 2013-2017. Ann Tropic Med Public Health 2018;17:S804.
Neamţu SD, Novac MB, Neamţu AV, et al. Fetal-maternal incompatibility in the Rh system. Rh isoimmunization associated with hereditary spherocytosis: case presentation and review of the literature. Rom J Morphol Embryol 2022;63:229-35.
DOI: https://doi.org/10.47162/RJME.63.1.26
Nazarchuk O, Dmyrtriiev D, Babina Y, et al. Research of the activity of local anesthetics and antiseptics regarding clinical isolates of Acinetobacter baumannii as pathogens of postoperative infectious complications. Acta Biomed 2022;93:e2022003.
Kulyk II, Khmil SV. Endometriosis-associated infertility: the role of hormones and its correction. Int J Med Med Res 2020;6:5-10.
DOI: https://doi.org/10.11603/ijmmr.2413-6077.2020.2.12011
Mialiuk OP, Sabadyshyn RO, Demianchuk MR, et al. Biochemical indices of blood in women suffering from anovulatory infertility during xenical treatment. Bull Med Biol Res 2022;4:75-9.
DOI: https://doi.org/10.11603/bmbr.2706-6290.2022.1.12902
Sultana S, Nallari P, Ananthapur V. Recurrent pregnancy loss (RPL): an overview. J Womens Health Dev 2020;3:302-15.
DOI: https://doi.org/10.26502/fjwhd.2644-28840038
Moshkalova G, Karibayeva I, Kurmanova A, et al. Endometrial thickness and live birth rates after IVF: a systematic review. Acta Biomed 2023;94:e2023152.
van Dijk MM, Kolte AM, Limpens J, et al. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update 2020;26:356-67.
DOI: https://doi.org/10.1093/humupd/dmz048
Yu N, Kwak-Kim J, Bao S. Unexplained recurrent pregnancy loss: novel causes and advanced treatment. J Reprod Immunol 2023;155:103785.
DOI: https://doi.org/10.1016/j.jri.2022.103785
Dimitriadis E, Menkhorst E, Saito S, et al. Recurrent pregnancy loss. Nat Rev Dis Primers 2020;6:98.
DOI: https://doi.org/10.1038/s41572-020-00228-z
Ali S, Majid S, Ali MN, et al. Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients. Saudi J Biol Sci 2020;27:2809-17.
DOI: https://doi.org/10.1016/j.sjbs.2020.06.049
Barbaro G, Inversetti A, Cristodoro M, et al. HLA-G and recurrent pregnancy loss. Int J Mol Sci 2023;24:2557.
DOI: https://doi.org/10.3390/ijms24032557
Pirtea P, Cicinelli E, De Nola R, et al. Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis. Fertil Steril 2021;115:546-60.
DOI: https://doi.org/10.1016/j.fertnstert.2020.12.010
Khmil Doswald АS, Malanchuk LM. Hysteroscopic and morphological evaluation of endometrium in reproductive age women with comorbid polycystic ovarian syndrome and chronic endometritis in the protocols of in vitro fertilization. Bull Med Biol Res 2022;4:103-9.
DOI: https://doi.org/10.11603/bmbr.2706-6290.2022.1.12936
Thomsen CK, Steffensen R, Nielsen HS, et al. HLA-DRB1 polymorphism in recurrent pregnancy loss: new evidence for an association to HLA-DRB1*07. J Reprod Immunol 2021;145:103308.
DOI: https://doi.org/10.1016/j.jri.2021.103308
Aimagambetova G, Kapasheva A, Bahia W, et al. Maternal HLA class II alleles and haplotypes associated with altered risk of recurrent pregnancy loss: a case‐control study. Am J Reprod Immunol 2024;91:e13817.
DOI: https://doi.org/10.1111/aji.13817
Ajmal L, Ajmal S, Ajmal M, et al. HLA system and its participation in recurrent pregnancy loss. Pak J Zool 2022;54:1905-16.
DOI: https://doi.org/10.17582/journal.pjz/20210826180821
Irinyenikan TA. Risk factors for female infertility at a tertiary health facility in Akure, South-West Nigeria. Int J Med Med Res 2019;5:61-8.
DOI: https://doi.org/10.11603/ijmmr.2413-6077.2019.2.10388
Elbaşı MO, Tulunay A, Karagözoğlu H, et al. Maternal killer-cell immunoglobulin-like receptors and paternal human leukocyte antigen ligands in recurrent pregnancy loss cases in Turkey. Clin Exp Reprod Med 2020;47:122-9.
DOI: https://doi.org/10.5653/cerm.2019.03223
Zaychenko GV, Karpenko NO, Striga EA, Sinitsyna OS. Pharmacological management of menopausal disorders: the phytoestrogenes (review). Probl Endocr Pathol 2018;66:65-74.
DOI: https://doi.org/10.21856/j-PEP.2018.4.07
Schapovalova O, Gorlova A, de Munter J, et al. Immunomodulatory effects of new phytotherapy on human macrophages and TLR4- and TLR7/8-mediated viral-like inflammation in mice. Front Med 2022;9:952977.
DOI: https://doi.org/10.3389/fmed.2022.952977
How to Cite
Aliyeva, G., Tarverdiyeva, S., & Ibrahimov, M. (2024). New aspects of immunological risk factors in the treatment of recurrent pregnancy loss. Healthcare in Low-Resource Settings. https://doi.org/10.4081/hls.2024.12563
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.